Amzak Capital Management Investments

Amzak Capital Management has invested in 21 companies and its latest investment was ShiraTronics on Sep 16, 2024

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

ShiraTronics is a Minnesota-based biotechnology company that develops and commercializes therapies for the treatment of migraine.
$37.4M
Sep 16, 2024
Jun 01, 2019
Neuros Medical is a California-based medical device company that designs and develops bioelectric nerve block systems for patients with intractable post-amputation pain.
$8.2M
Nov 14, 2022
-
Antios is a Georgia-based biopharmaceutical company that develops and commercializes therapies for the treatment of viral diseases.
$75M
Nov 02, 2021
-
$19M
Aug 09, 2021
-
Antios is a Georgia-based biopharmaceutical company that develops and commercializes therapies for the treatment of viral diseases.
$96M
Apr 11, 2021
-

Frequently Asked Questions about Amzak Capital Management

  1. What is Amzak Capital Management investing in?

    Amzak Capital Management has invested in 21 companies including ShiraTronics, Neuros Medical and Antios
  2. What company did Amzak Capital Management invest in?

    Amzak Capital Management invested in a total 21 companies including ShiraTronics, Neuros Medical and Antios
  1. What are the top 5 investments by Amzak Capital Management?

    The top companies in which Amzak Capital Management invested are ShiraTronics, Neuros Medical, Antios, Thryv and Antios